2016 VINCENT du VIGNEAUD AWARDS OF EXCELLENCE
BEST STUDENT TALK AWARD:
Emily Mercer , 6th year Pharmacology student, 1ST PLACE: “Evidence that HSPB7 Chaperone Coordinates Cardiac Cytoskeletal Turnover” (Professor Todd Evans)
2016 VINCENT du VIGNEAUD BEST SECOND-YEAR POSTER AND ABOVE AWARDS
Ron S. Gejman , 1st PLACE, “A High-Throughput, Cell-Based Method for Screening T Cell Receptor Mimic Antibodies Against Major Histocompatibility Complex Ligands” (Professor David Scheinberg)
2015 VINCENT du VIGNEAUD AWARDS OF EXCELLENCE
BEST STUDENT TALK AWARD:
Christina Bonvicino , 5th year Pharmacology student, 1ST PLACE: “"Isoflurance Depresses Dopamine Synaptic Vesicle Exocytosis” (Professor Hugh Hemmings)
2015 VINCENT du VIGNEAUD BEST SECOND-YEAR POSTER AND ABOVE AWARDS
Abigail Horstmann , 1st PLACE, “ALDH1A2 (RALDH2) in Oral Cavity Squamous Cell Carcinoma” (Professor Lorraine Gudas)
2015 VINCENT du VIGNEAUD BEST FIRST YEAR POSTER PRESENTER AWARD
Lauren Forbes, 2nd PLACE, “, Nanoparticle Properties and their Effect on Stability and Distribution” (Professor Daniel Heller)
2014 VINCENT du VIGNEAUD AWARDS OF EXCELLENCE
BEST ORAL PRESENTATION:
Christina Maksymiuk , 6th year Pharmacology student: “Characterization of 2-hydroxy-3-oxoadipate synthase (HOAS) in Mycobacterium Tuberculosis Metabolism” (Professor Carl Nathan)
2014 VINCENT du VIGNEAUD BEST SECOND-YEAR POSTER AWARDS
Charles Ferranti , “Ionizing Radiation-Induced "Nanopores" Signal Acid Sphingomyelinase Activation and Cell Surface Translocation” (Professor Richard Kolesnick)
Bonnie Quach , “Mechanism of Preventing Doxorubicin-Induced Mitochondrial Toxicity with Cardiolipin- Targeted Peptide, SS-31” (Professor Hazel Szeto)
2014 JULIAN R. RACHELE PRIZE
Joseph Justin Mulvey , “Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery” (Professor David Scheinberg)
2013 VINCENT du VIGNEAUD AWARDS OF EXCELLENCE
2013 VINCENT du VIGNEAUD FIRST YEAR AWARD
Wan-Ying Hsieh , “Direct Target Analysis of the MUSASHI2 RNA Binding Protein Uncovers Developmental Pathways that Control HSC Self-Renewal” (Professor Michael Kharas)
2013 VINCENT du VIGNEAUD BEST SECOND YEAR AWARD
Emily Mercer , “Elucidating the Role of HSPB7 in the Heart ” (Professor Todd Evans)
2013 JULIAN R. RACHELE PRIZE
Elissaveta Petrova , “Inhibitors of Hedgehog Acyltransferase Block Sonic Hedgehog Signaling ” (Professor Marilyn Resh)
2012 VINCENT du VIGNEAUD AWARDS OF EXCELLENCE
Jamie L. McBean , 4th year Pharmacology student: “Elucidation of the Substrate Profile of Protein Methyltransferase SET7/9.” (Professor Minkui Luo)
2012 VINCENT du VIGNEAUD FIRST-YEAR AWARDS
William Mills , “Characterization of Szeto-Schiller Tetrapeptide/Phospholipid Binding.” (Professor Hazel Szeto)
Suranjit Mukherjee , “Development of New Heteroclitic Peptides for B702 and A3/A11 HLA Types for WT1.” (Professor David Scheinberg)
Vincent du Vigneaud Symposium Awards, April 28, 2011
Mark Lundquist, a Pharmacology student, was awarded the only oral presentation prize at this year's Vincent du Vigneaud Symposium! The title of his talk was: "Mical-2 regulates nuclear actin dynamics".
Vincent du Vigneaud Symposium Awards, May 4, 2010
Alex R. Hansler, a third year Pharmacology student, was awarded the Vincent du Vigneaud Award of Excellence for poster presentations. The Vincent du Vigneaud Award of Excellence for oral presentations was presented to Ronald S. Bultje, a fifth year Pharmacology student. The Vincent du Vigneaud First-Year Award was given to Rebecca L. Goldstein, a first year Pharmacology student.
Congratulations to Dr. Geoffrey Ling, the Weill Cornell Graduate School of Medical Sciences Distinguished Alumnus Award Recipient of 2009.
Colonel Geoffrey S.F. Ling, M.D., PH.D. '82 is Professor and Vice Chairman of the Neurology Department at the Uniformed Services University of the Health Sciences (USUHS), director of Neurocritical care at Walter Reed Army Medical Center and attending neurocritical care physician at Johns Hopkins Hospital.
He is an active duty Colonel in the U.S. Army and the only board certified neurocritical care specialist in the Department of Defense. He served in Afghanistan and Baghdad, Iraq.
Col. Ling entered Weill Cornell Graduate School of Medical Sciences to pursue a doctorate in Pharmacology, which he received in 1982 for his studies of physical dependence and tolerance to methadone in the rat. After three years of postdoctoral training in neuropharmacology at the Memorial Sloan-Kettering Cancer Center, he entered Georgetown University School of Medicine, Washington, D.C., where he earned the M.D. degree in 1989. He completed both neurology internship and a neurology residency at Walter Reed Army Medical Center, Washington, D.C. He also completed a fellowship in the Neurosciences Critical Care Unit, Johns Hopkins University.
Col. Ling leads the neurotrauma laboratory at USUHS. The focus areas are basic and applied research in traumatic brain injury with studies on the role of cytokines and cell cycle regulators in central nervous system inflammation and cell death, as well as application of novel technologies and pharmacologic agents to diagnose and treat this disease. He has received numerous national awards and has published over 100 peer-reviewed journal articles, reviews and book chapters, including Cecil's Textbook of Medicine.
Col. Ling is also a program manager with the Defense Advances Research Projects Agency. His portfolio focuses on restoring those injured in battle and preventing future injury. These programs include the development of advanced prosthetic limbs, pre-symptomatic disease detection, and determining causes of and potential mitigation strategies for traumatic brain injuries caused by explosion.
On June 1st, 2009, Dr. Ling gave a special seminar, which was followed by a reception, for Pharmacology graduate students and postdoctoral fellows.